It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The aim of this study was to test the use of IP-10 detection in dried plasma from contact studies individuals (contacts of smear positive patients), by comparing it with IP-10 and IFN-γ detection in direct plasma, to establish IP-10 detection in DPS as a useful assay for LTBI diagnosis. Whole blood samples were collected from 80 subjects: 12 with active tuberculosis (TB), and 68 from contact studies. The amount of IFN-γ produced by sensitized T cells was determined in direct plasma by QuantiFERON Gold In-Tube test. IP-10 levels were determined in direct and dried plasma by an in-house ELISA. For dried plasma IP-10 determination, two 25 µl plasma drops were dried in Whatman903 filter paper and sent by mail to the laboratory. Regarding TB patients, 100.0%, 91.7% and 75.0% were positive for IFN-γ detection and IP-10 detection in direct and dried plasma, respectively. In contacts, 69.1%, 60.3% and 48.5% had positive results after IFN-γ and IP-10 in direct and dried plasma, respectively. The agreement among in vitro tests was substantial and IP-10 levels in direct and dried plasma were strongly correlated (r = 0.897). In conclusion, IP-10 detection in dried plasma is a simple and safe method that would help improve LTBI management.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Servei de Microbiología, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Carretera del Canyet, 08916 Badalona, Barcelona, Spain (GRID:grid.411438.b) (ISNI:0000 0004 1767 6330); CIBERES, Instituto de Salud Carlos III, Carretera del Canyet, 08916 Badalona, CIBER Enfermedades Respiratorias, Barcelona, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Universitat Autònoma de Barcelona, Carretera del Canyet, 08916 Badalona, Barcelona, Spain (GRID:grid.7080.f)
2 Hospital Universitari Vall d’Hebron. Av. de les Drassanes, 17, 08001 Barcelona, Unitat de Tuberculosi de Drassanes, Barcelona, Spain (GRID:grid.411083.f) (ISNI:0000 0001 0675 8654)
3 CIBERES, Instituto de Salud Carlos III, Carretera del Canyet, 08916 Badalona, CIBER Enfermedades Respiratorias, Barcelona, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Universitat Autònoma de Barcelona, Carretera del Canyet, 08916 Badalona, Barcelona, Spain (GRID:grid.7080.f); Hospital Universitari Germans Trias i Pujol, Carretera del Canyet, 08916 Badalona, Servei de Pneumologia, Barcelona, Spain (GRID:grid.411438.b) (ISNI:0000 0004 1767 6330)
4 Hospital Universitari Vall d’Hebron. Av. de les Drassanes, 17, 08001 Barcelona, Unitat de Tuberculosi de Drassanes, Barcelona, Spain (GRID:grid.411083.f) (ISNI:0000 0001 0675 8654); Unidad Clínica de Tratamiento Directamente Observado “Serveis Clinics”, Carrer de García Mariño, 4, Barcelona, Spain (GRID:grid.411083.f); Instituto de Salud Carlos III, Carretera del Canyet, 08916 Badalona, CIBER de Epidemiología y Salud Pública, CIBEREESP, Barcelona, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
5 Unidad Clínica de Tratamiento Directamente Observado “Serveis Clinics”, Carrer de García Mariño, 4, Barcelona, Spain (GRID:grid.413448.e); Instituto de Salud Carlos III, Carretera del Canyet, 08916 Badalona, CIBER de Epidemiología y Salud Pública, CIBEREESP, Barcelona, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
6 Unidad Clínica de Tratamiento Directamente Observado “Serveis Clinics”, Carrer de García Mariño, 4, Barcelona, Spain (GRID:grid.413448.e)
7 Copenhagen, Denmark - Artillerivej 5, Department of Infectious Disease Immunology Statens Serum Institut, Copenhagen, Denmark (GRID:grid.6203.7) (ISNI:0000 0004 0417 4147)